Title : Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.

Pub. Date : 2012 Jan

PMID : 21567511






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The observation suggested that combined treatment of a low dosage of curcumin with inhibitors against epidermal growth factor receptor (EGFR), insulin-like growth factor 1 (IGF-1R), fibroblast growth factors receptor (FGFR), phosphatidylinositol 3-kinases (PI3K) or NF-kappaB signaling pathway may be a potential adjuvant therapy beneficial to NSCLC patients. Curcumin epidermal growth factor receptor Homo sapiens
2 The observation suggested that combined treatment of a low dosage of curcumin with inhibitors against epidermal growth factor receptor (EGFR), insulin-like growth factor 1 (IGF-1R), fibroblast growth factors receptor (FGFR), phosphatidylinositol 3-kinases (PI3K) or NF-kappaB signaling pathway may be a potential adjuvant therapy beneficial to NSCLC patients. Curcumin epidermal growth factor receptor Homo sapiens